Fol. Biol. 2019, 65, 227-236

https://doi.org/10.14712/fb2019065050227

Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis

Oskar Zakiyanov1, Z. Chocová1, Z. Hrušková1,2, Z. Hladinová1, Marta Kalousová3, K. Malíčková3, V. Bednářová1, J. Vachek1, P. Wurmová1, V. Kříha4, T. Zima3, V. Tesař1

1Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
3Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
4Institute of Radiation Oncology, Bulovka Hospital, Prague, Czech Republic

Received July 2019
Accepted October 2019

Crossref Cited-by Linking

  • Negrin Lukas L., Carlin Greta L., Ristl Robin, Hajdu Stefan, van Wijnen Andre: Serum levels of matrix metalloproteinases 1, 2, and 7, and their tissue inhibitors 1, 2, 3, and 4 in polytraumatized patients: Time trajectories, correlations, and their ability to predict mortality. PLoS ONE 2024, 19, e0300258. <https://doi.org/10.1371/journal.pone.0300258>
  • Jain Sahil, Sangle Shirish R., Kim Sangmi, John Susan, D’Cruz David: Hydroxychloroquine as a potential therapy for ANCA-associated vasculitis. Vessel Plus 2024. <https://doi.org/10.20517/2574-1209.2023.142>
  • Teisseire Manon, Giuliano Sandy, Pagès Gilles: Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?. Biomedicines 2024, 12, 385. <https://doi.org/10.3390/biomedicines12020385>
  • Dissemond Joachim, Romanelli Marco: Inflammatory skin diseases and wounds. Br J Dermatol 2022, 187, 167. <https://doi.org/10.1111/bjd.21619>
  • Rymarz Aleksandra, Mosakowska Magdalena, Niemczyk Stanisław: The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis. Sci Rep 2021, 11. <https://doi.org/10.1038/s41598-021-84662-3>
Crossref Cited-by Linking logo